COPS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.042600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.602400E-01
Normal-vs-Stage2
2.740200E-01
Normal-vs-Stage3
9.021600E-02
Normal-vs-Stage4
2.769200E-01
Stage1-vs-Stage2
5.680400E-01
Stage1-vs-Stage3
3.515800E-01
Stage1-vs-Stage4
7.441000E-01
Stage2-vs-Stage3
4.525000E-01
Stage2-vs-Stage4
9.597800E-01
Stage3-vs-Stage4
4.955400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.424000E-01
Normal-vs-AfricanAmerican
3.886400E-01
Normal-vs-Asian
2.543600E-02
Caucasian-vs-AfricanAmerican
7.489400E-01
Caucasian-vs-Asian
5.462000E-02
AfricanAmerican-vs-Asian
8.243500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.602600E-01
Normal-vs-Female
5.712800E-01
Male-vs-Female
2.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.305000E-01
Normal-vs-Age(41-60Yrs)
8.155200E-01
Normal-vs-Age(61-80Yrs)
1.905840E-01
Normal-vs-Age(81-100Yrs)
1.031210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.715400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.235200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.150800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.608270E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.986100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.204200E-02
Normal-vs-Daily Drinker
8.249800E-02
Normal-vs-Weekly Drinker
7.618200E-01
Normal-vs-Occasional Drinker
7.615800E-01
Normal-vs-Social Drinker
5.948800E-01
Non Drinker-vs-Daily Drinker
9.836400E-01
Non Drinker-vs-Weekly Drinker
2.606200E-01
Non Drinker-vs-Occasional Drinker
7.710300E-02
Non Drinker-vs-Social Drinker
1.931810E-01
Daily Drinker-vs-Weekly Drinker
2.707000E-01
Daily Drinker-vs-Occasional Drinker
9.251500E-02
Daily Drinker-vs-Social Drinker
1.765370E-01
Weekly Drinker-vs-Occasional Drinker
9.265000E-01
Weekly Drinker-vs-Social Drinker
7.386600E-01
Occasional Drinker-vs-Social Drinker
7.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.949600E-01
Normal-vs-Grade 2
6.313600E-01
Normal-vs-Grade 3
6.280800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.168400E-02
Grade 1-vs-Grade 3
1.815540E-02
Grade 1-vs-Grade 4
6.949600E-01
Grade 2-vs-Grade 3
8.008200E-01
Grade 2-vs-Grade 4
6.313600E-01
Grade 3-vs-Grade 4
6.280800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.384180E-01
Normal-vs-NonDiabetic
4.506800E-01
Diabetic-vs-NonDiabetic
2.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.776200E-02
Normal-vs-NoPancreatitis
4.195400E-01
Pancreatitis-vs-NoPancreatitis
2.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.867000E-01
Normal-vs-N1
2.928800E-01
N0-vs-N1
1.745620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.041400E-01
Normal-vs-TP53-NonMutant
9.135800E-01
TP53-Mutant-vs-TP53-NonMutant
1.880730E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
